- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/96 - Sulfur atom
Patent holdings for IPC class C07D 211/96
Total number of patents in this class: 361
10-year publication summary
|
27
|
27
|
29
|
26
|
28
|
21
|
31
|
19
|
30
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19803 |
13 |
| F. Hoffmann-La Roche AG | 7920 |
9 |
| Helsinn Healthcare SA | 229 |
8 |
| Bristol-myers Squibb Company | 4897 |
7 |
| Takeda Pharmaceutical Company Limited | 2703 |
7 |
| FUJIFILM Corporation | 29208 |
6 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 282 |
5 |
| Board of Regents, The University of Texas System | 5745 |
5 |
| Toray Industries, Inc. | 6886 |
5 |
| Arete Therapeutics, Inc. | 23 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 689 |
5 |
| Shionogi & Co., Ltd. | 868 |
5 |
| Novartis AG | 10927 |
4 |
| Boehringer Ingelheim International GmbH | 4701 |
4 |
| California Institute of Technology | 3966 |
4 |
| Abbvie Inc. | 1800 |
4 |
| Amicus Therapeutics, Inc. | 350 |
4 |
| Axikin Pharmaceuticals, Inc. | 14 |
4 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 931 |
4 |
| Incyte Corporation | 1005 |
4 |
| Other owners | 249 |